190 related articles for article (PubMed ID: 37867176)
1. Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease.
Iyaswamy A; Thakur A; Guan XJ; Krishnamoorthi S; Fung TY; Lu K; Gaurav I; Yang Z; Su CF; Lau KF; Zhang K; Ng RC; Lian Q; Cheung KH; Ye K; Chen HJ; Li M
Signal Transduct Target Ther; 2023 Oct; 8(1):404. PubMed ID: 37867176
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice: A Novel Mechanism Presenting the Protein Fe65 as a Target.
Szögi T; Schuster I; Borbély E; Gyebrovszki A; Bozsó Z; Gera J; Rajkó R; Sántha M; Penke B; Fülöp L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234498
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing.
Chow WN; Ngo JC; Li W; Chen YW; Tam KM; Chan HY; Miller CC; Lau KF
Biochem J; 2015 Sep; 470(3):303-17. PubMed ID: 26188042
[TBL] [Abstract][Full Text] [Related]
4. Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer's disease models.
Guan XJ; Deng ZQ; Liu J; Su CF; Tong BC; Zhu Z; Sreenivasmurthy SG; Kan YX; Lu KJ; Chu CP; Pi RB; Cheung KH; Iyaswamy A; Song JX; Li M
Acta Pharmacol Sin; 2024 May; 45(5):900-913. PubMed ID: 38225393
[TBL] [Abstract][Full Text] [Related]
5. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
Lee M; Ban JJ; Yang S; Im W; Kim M
Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
[TBL] [Abstract][Full Text] [Related]
6. The FE65 proteins and Alzheimer's disease.
McLoughlin DM; Miller CC
J Neurosci Res; 2008 Mar; 86(4):744-54. PubMed ID: 17828772
[TBL] [Abstract][Full Text] [Related]
7. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K
Cells; 2022 Nov; 11(23):. PubMed ID: 36497090
[TBL] [Abstract][Full Text] [Related]
8. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Fe65 adapter protein in adult and developing mouse brain.
Kesavapany S; Banner SJ; Lau KF; Shaw CE; Miller CC; Cooper JD; McLoughlin DM
Neuroscience; 2002; 115(3):951-60. PubMed ID: 12435432
[TBL] [Abstract][Full Text] [Related]
10. FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles.
Delatour B; Mercken L; El Hachimi KH; Colle MA; Pradier L; Duyckaerts C
Am J Pathol; 2001 May; 158(5):1585-91. PubMed ID: 11337355
[TBL] [Abstract][Full Text] [Related]
11. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.
Borg JP; Ooi J; Levy E; Margolis B
Mol Cell Biol; 1996 Nov; 16(11):6229-41. PubMed ID: 8887653
[TBL] [Abstract][Full Text] [Related]
12. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction.
Fombonne J; Rabizadeh S; Banwait S; Mehlen P; Bredesen DE
Ann Neurol; 2009 Mar; 65(3):294-303. PubMed ID: 19334058
[TBL] [Abstract][Full Text] [Related]
13. Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein.
Sabo SL; Lanier LM; Ikin AF; Khorkova O; Sahasrabudhe S; Greengard P; Buxbaum JD
J Biol Chem; 1999 Mar; 274(12):7952-7. PubMed ID: 10075692
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins.
Zambrano N; Buxbaum JD; Minopoli G; Fiore F; De Candia P; De Renzis S; Faraonio R; Sabo S; Cheetham J; Sudol M; Russo T
J Biol Chem; 1997 Mar; 272(10):6399-405. PubMed ID: 9045663
[TBL] [Abstract][Full Text] [Related]
15. Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction.
Feilen LP; Haubrich K; Strecker P; Probst S; Eggert S; Stier G; Sinning I; Konietzko U; Kins S; Simon B; Wild K
Front Mol Neurosci; 2017; 10():140. PubMed ID: 28553201
[TBL] [Abstract][Full Text] [Related]
16. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
17. Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD.
Nakaya T; Suzuki T
Genes Cells; 2006 Jun; 11(6):633-45. PubMed ID: 16716194
[TBL] [Abstract][Full Text] [Related]
18. Overproduction, purification, crystallization and preliminary X-ray analysis of human Fe65-PTB2 in complex with the amyloid precursor protein intracellular domain.
Radzimanowski J; Beyreuther K; Sinning I; Wild K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 May; 64(Pt 5):409-12. PubMed ID: 18453713
[TBL] [Abstract][Full Text] [Related]
19. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis.
Ma QH; Futagawa T; Yang WL; Jiang XD; Zeng L; Takeda Y; Xu RX; Bagnard D; Schachner M; Furley AJ; Karagogeos D; Watanabe K; Dawe GS; Xiao ZC
Nat Cell Biol; 2008 Mar; 10(3):283-94. PubMed ID: 18278038
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
